10-Q Filing

GLOBUS MEDICAL INC CIK: 1237831 Q3 2014

Filing Information

Form Type	10-Q
Accession Number	`0001237831-14-000048`
Period End Date	20140930
Filing Date	20141031
Fiscal Year	2014
Fiscal Period	Q3
XBRL Instance	gmed-20140930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 76 Cash Flow Statement 66 Comprehensive Income 20

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$212.40M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$169.45M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$89.96M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.73M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$101.91M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.58M	USD	Point-in-time
Short-term marketable securities	`AvailableForSaleSecuritiesCurrent`	$148.96M	USD	Point-in-time
Short-term marketable securities	`AvailableForSaleSecuritiesCurrent`	$129.30M	USD	Point-in-time
Accounts receivable, net of allowances of $1,733 and $1,581, respectively	`AccountsReceivableNetCurrent`	$62.41M	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$99.91M	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$113.87M	USD	Point-in-time
Accounts receivable, net of allowances of $1,733 and $1,581, respectively	`AccountsReceivableNetCurrent`	$62.60M	USD	Point-in-time
Inventories	`InventoryNet`	$77.43M	USD	Point-in-time
Inventories	`InventoryNet`	$70.35M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.18M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.08M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	785.00M	shares	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	$2.72M	USD	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	$2.10M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	785.00M	shares	Point-in-time
Deferred income taxes	`DeferredTaxAssetsNetCurrent`	$37.75M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	94.46M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	93.44M	shares	Point-in-time
Deferred income taxes	`DeferredTaxAssetsNetCurrent`	$37.32M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	93.44M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	94.46M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$484.81M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$416.81M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $113,868 and $99,910, respectively	`PropertyPlantAndEquipmentNet`	$66.06M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $113,868 and $99,910, respectively	`PropertyPlantAndEquipmentNet`	$64.15M	USD	Point-in-time
Long-term marketable securities	`AvailableForSaleSecuritiesNoncurrent`	$36.53M	USD	Point-in-time
Long-term marketable securities	`AvailableForSaleSecuritiesNoncurrent`	$47.03M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$29.14M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$29.54M	USD	Point-in-time
Goodwill	`Goodwill`	$18.37M	USD	Point-in-time
Goodwill	`Goodwill`	$18.37M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.02M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$909.00K	USD	Point-in-time
Total assets	`Assets`	$646.44M	USD	Point-in-time
Total assets	`Assets`	$566.30M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.07M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$9.70M	USD	Point-in-time
Accounts payable to related-party	`AccountsPayableRelatedPartiesCurrent`	$3.94M	USD	Point-in-time
Accounts payable to related-party	`AccountsPayableRelatedPartiesCurrent`	$2.66M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$51.12M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$55.61M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$2.36M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$2.06M	USD	Point-in-time
Business acquisition liabilities, current	`BusinessAcquisitionLiabilitiesCurrent`	$1.73M	USD	Point-in-time
Business acquisition liabilities, current	`BusinessAcquisitionLiabilitiesCurrent`	$1.44M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$72.76M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$67.94M	USD	Point-in-time
Business acquisition liabilities, net of current portion	`BusinessAcquisitionLiabilitiesNoncurrent`	$15.35M	USD	Point-in-time
Business acquisition liabilities, net of current portion	`BusinessAcquisitionLiabilitiesNoncurrent`	$15.53M	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$1.73M	USD	Point-in-time
Deferred income taxes	`DeferredTaxLiabilitiesNoncurrent`	$6.38M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$2.79M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$4.09M	USD	Point-in-time
Total liabilities	`Liabilities`	$92.63M	USD	Point-in-time
Total liabilities	`Liabilities`	$93.94M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock; $0.001 par value. Authorized 785,000 shares; issued and outstanding 94,464 and 93,443 shares at September 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$94.00K	USD	Point-in-time
Common stock; $0.001 par value. Authorized 785,000 shares; issued and outstanding 94,464 and 93,443 shares at September 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$93.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$170.88M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$153.99M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-767.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.12M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.31M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.01M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$319.29M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$384.14M	USD	Point-in-time
Total equity	`StockholdersEquity`	$472.36M	USD	Point-in-time
Total equity	`StockholdersEquity`	$553.81M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$566.30M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$646.44M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Sales	`SalesRevenueNet`	$107.19M	USD	1 Quarter
Sales	`SalesRevenueNet`	$117.79M	USD	1 Quarter
Sales	`SalesRevenueNet`	$319.21M	USD	3 Qtrs
Sales	`SalesRevenueNet`	$345.57M	USD	3 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$27.69M	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$25.32M	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$72.31M	USD	3 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$79.58M	USD	3 Qtrs
Provision for litigation - cost of goods sold	`Provisionforlitigationlosscostofgoodssold`	-	USD	3 Qtrs
Provision for litigation - cost of goods sold	`Provisionforlitigationlosscostofgoodssold`	-	USD	1 Quarter
Provision for litigation - cost of goods sold	`Provisionforlitigationlosscostofgoodssold`	-	USD	1 Quarter
Provision for litigation - cost of goods sold	`Provisionforlitigationlosscostofgoodssold`	$1.26M	USD	3 Qtrs
Gross profit	`GrossProfit`	$90.10M	USD	1 Quarter
Gross profit	`GrossProfit`	$81.87M	USD	1 Quarter
Gross profit	`GrossProfit`	$265.99M	USD	3 Qtrs
Gross profit	`GrossProfit`	$245.65M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$6.57M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$8.15M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$20.45M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$23.28M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$46.99M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$140.09M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$136.85M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$45.70M	USD	1 Quarter
Provision for litigation	`LossContingencyAccrualProvision`	$46.00K	USD	1 Quarter
Provision for litigation	`LossContingencyAccrualProvision`	$99.00K	USD	1 Quarter
Provision for litigation	`LossContingencyAccrualProvision`	$18.42M	USD	3 Qtrs
Provision for litigation	`LossContingencyAccrualProvision`	$3.90M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$52.37M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$55.18M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$167.27M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$175.72M	USD	3 Qtrs
Operating Income	`OperatingIncomeLoss`	$34.92M	USD	1 Quarter
Operating Income	`OperatingIncomeLoss`	$69.93M	USD	3 Qtrs
Operating Income	`OperatingIncomeLoss`	$29.50M	USD	1 Quarter
Operating Income	`OperatingIncomeLoss`	$98.72M	USD	3 Qtrs
Other income/(expense), net	`OtherNonoperatingIncomeExpense`	$197.00K	USD	1 Quarter
Other income/(expense), net	`OtherNonoperatingIncomeExpense`	$446.00K	USD	3 Qtrs
Other income/(expense), net	`OtherNonoperatingIncomeExpense`	$255.00K	USD	3 Qtrs
Other income/(expense), net	`OtherNonoperatingIncomeExpense`	$-124.00K	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$70.18M	USD	3 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$29.70M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$99.16M	USD	3 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$34.80M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$34.32M	USD	3 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$9.39M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$11.74M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$22.55M	USD	3 Qtrs
Net Income	`NetIncomeLoss`	$64.85M	USD	3 Qtrs
Net Income	`NetIncomeLoss`	$20.31M	USD	1 Quarter
Net Income	`NetIncomeLoss`	$47.63M	USD	3 Qtrs
Net Income	`NetIncomeLoss`	$23.06M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.22	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.52	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.69	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.24	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.51	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.22	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.24	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.68	USD	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	93.03M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	94.40M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	92.42M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	94.11M	shares	3 Qtrs
Dilutive stock options	`IncrementalCommonSharesAttributableToShareBasedPaymentArrangements`	1.39M	shares	1 Quarter
Dilutive stock options	`IncrementalCommonSharesAttributableToShareBasedPaymentArrangements`	1.27M	shares	3 Qtrs
Dilutive stock options	`IncrementalCommonSharesAttributableToShareBasedPaymentArrangements`	1.63M	shares	3 Qtrs
Dilutive stock options	`IncrementalCommonSharesAttributableToShareBasedPaymentArrangements`	1.08M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	94.04M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.38M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	94.42M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	95.47M	shares	1 Quarter
Anti-dilutive stock equivalents excluded from weighted average calculation	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	2.08M	shares	3 Qtrs
Anti-dilutive stock equivalents excluded from weighted average calculation	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	1.66M	shares	1 Quarter
Anti-dilutive stock equivalents excluded from weighted average calculation	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	1.62M	shares	1 Quarter
Anti-dilutive stock equivalents excluded from weighted average calculation	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	1.52M	shares	3 Qtrs

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$64.85M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$20.31M	USD	1 Quarter
Net income	`NetIncomeLoss`	$47.63M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$23.06M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$16.06M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.21M	USD	3 Qtrs
Amortization of premium on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.48M	USD	3 Qtrs
Amortization of premium on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-2.07M	USD	3 Qtrs
Provision for excess and obsolete inventories	`InventoryWriteDown`	$6.41M	USD	3 Qtrs
Provision for excess and obsolete inventories	`InventoryWriteDown`	$5.44M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$3.87M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$5.21M	USD	3 Qtrs
Allowance for doubtful accounts	`ProvisionForDoubtfulAccounts`	$234.00K	USD	3 Qtrs
Allowance for doubtful accounts	`ProvisionForDoubtfulAccounts`	$236.00K	USD	3 Qtrs
Change in deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-11.14M	USD	3 Qtrs
Change in deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-5.12M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$886.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.14M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$15.71M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$12.54M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.32M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.59M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.25M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.02M	USD	3 Qtrs
Accounts payable to related-party	`IncreaseDecreaseInAccountsPayableRelatedParties`	$730.00K	USD	3 Qtrs
Accounts payable to related-party	`IncreaseDecreaseInAccountsPayableRelatedParties`	$1.29M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$19.64M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$3.85M	USD	3 Qtrs
Income taxes payable/receivable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-1.81M	USD	3 Qtrs
Income taxes payable/receivable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$334.00K	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$60.81M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$77.23M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireInvestments`	$186.75M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireInvestments`	$161.15M	USD	3 Qtrs
Maturities of marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$19.00M	USD	3 Qtrs
Maturities of marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$144.21M	USD	3 Qtrs
Sales of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	$4.98M	USD	3 Qtrs
Sales of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	$24.03M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.66M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$18.48M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.57M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-181.24M	USD	3 Qtrs
Payment of business acquisition liabilities	`PaymentOfBusinessAcquisitionLiabilities`	$1.00M	USD	3 Qtrs
Payment of business acquisition liabilities	`PaymentOfBusinessAcquisitionLiabilities`	$900.00K	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$7.64M	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$6.22M	USD	3 Qtrs
Excess tax benefit related to nonqualified stock options	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$4.04M	USD	3 Qtrs
Excess tax benefit related to nonqualified stock options	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$4.52M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.74M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.79M	USD	3 Qtrs
Effect of foreign exchange rate on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$45.00K	USD	3 Qtrs
Effect of foreign exchange rate on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$198.00K	USD	3 Qtrs
Net increase/(decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$79.49M	USD	3 Qtrs
Net increase/(decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-110.49M	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$212.40M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$169.45M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$89.96M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$101.91M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$212.40M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$169.45M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$89.96M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$101.91M	USD	Point-in-time
Interest paid	`InterestPaid`	$42.00K	USD	3 Qtrs
Interest paid	`InterestPaid`	$32.00K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$36.36M	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$30.96M	USD	3 Qtrs

Comprehensive Income 20 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$64.85M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$20.31M	USD	1 Quarter
Net income	`NetIncomeLoss`	$47.63M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$23.06M	USD	1 Quarter
Unrealized gain/(loss) on marketable securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$13.00K	USD	3 Qtrs
Unrealized gain/(loss) on marketable securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$72.00K	USD	1 Quarter
Unrealized gain/(loss) on marketable securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-8.00K	USD	3 Qtrs
Unrealized gain/(loss) on marketable securities, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-18.00K	USD	1 Quarter
Foreign currency translation gain/(loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-290.00K	USD	3 Qtrs
Foreign currency translation gain/(loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$175.00K	USD	1 Quarter
Foreign currency translation gain/(loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-371.00K	USD	3 Qtrs
Foreign currency translation gain/(loss)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-422.00K	USD	1 Quarter
Total other comprehensive income/(loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$247.00K	USD	1 Quarter
Total other comprehensive income/(loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-298.00K	USD	3 Qtrs
Total other comprehensive income/(loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-440.00K	USD	1 Quarter
Total other comprehensive income/(loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-358.00K	USD	3 Qtrs
Comprehensive Income	`ComprehensiveIncomeNetOfTax`	$47.27M	USD	3 Qtrs
Comprehensive Income	`ComprehensiveIncomeNetOfTax`	$64.55M	USD	3 Qtrs
Comprehensive Income	`ComprehensiveIncomeNetOfTax`	$20.56M	USD	1 Quarter
Comprehensive Income	`ComprehensiveIncomeNetOfTax`	$22.62M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.